Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Other Biotechnology News
by ruth on October 19, 2006
Optimizer™ technology is based on a new method known as Cardiac Contractility Modulation (CCM). CCM is a method for treating failing hearts in which non-excitatory impulses are delivered to the heart during a period of time called the absolute refractory period (ARP). Therefore, these signals do not initiate the heart to beat (like a pacemaker would). Rather, these signals are intended to modify heart cell function for the treatment of heart failure.
Approximately 420 patients in about 50 sites nationwide will be enrolled in this trial. Patients who qualify will undergo surgery similar to putting in a pacemaker.
Recruitment are currenlty being done on major university hospitals across the country. If you would like to participate, or would like more information, check if you meet the eligibility criteria, or email info@impulse-dynamics.com.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/39672
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Optimizer III Implantable Pulse Generator Against Heart Failure:
|
Rating: 8.33 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
